LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
Yan, S. Betty, Peek, Victoria L., Ajamie, Rose, Buchanan, Sean G., Graff, Jeremy R., Heidler, Steven A., Hui, Yu-Hua, Huss, Karen L., Konicek, Bruce W., Manro, Jason R., Shih, Chuan, Stewart, Julie A., Stewart, Trent R., Stout, Stephanie L., Uhlik, Mark T., Um, Suzane L., Wang, Yong, Wu, Wenjuan, Yan, Lei, Yang, Wei J., Zhong, Boyu, Walgren, Richard A.
Published in Investigational new drugs (01.08.2013)
Published in Investigational new drugs (01.08.2013)
Get full text
Journal Article
The protein kinase Cβ-selective inhibitor, enzastaurin (LY317615.HCI), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts
GRAFF, Jeremy R, MCNULTY, Ann M, SAMS, Lillian, HUSS, Karen L, CAMPBELL, Robert M, IVERSEN, Philip W, NEUBAUER, Blake Lee, BROWN, Thomas J, MUSIB, Luna, GEEGANAGE, Sandaruwan, THORNTON, Donald, ROSS HANNA, Kimberly, KONICEK, Bruce W, LYNCH, Rebecca L, BAILEY, Spring N, BANKS, Crystal, CAPEN, Andrew, GOODE, Robin, LEWIS, Jason E
Published in Cancer research (Chicago, Ill.) (15.08.2005)
Published in Cancer research (Chicago, Ill.) (15.08.2005)
Get full text
Journal Article
Optimization of a Dihydropyrrolopyrazole Series of Transforming Growth Factor-β Type I Receptor Kinase Domain Inhibitors: Discovery of an Orally Bioavailable Transforming Growth Factor-β Receptor Type I Inhibitor as Antitumor Agent
Li, Hong-yu, McMillen, William T, Heap, Charles R, McCann, Denis J, Yan, Lei, Campbell, Robert M, Mundla, Sreenivasa R, King, Chi-Hsin R, Dierks, Elizabeth A, Anderson, Bryan D, Britt, Karen S, Huss, Karen L, Voss, Matthew D, Wang, Yan, Clawson, David K, Yingling, Jonathan M, Sawyer, J. Scott
Published in Journal of medicinal chemistry (10.04.2008)
Published in Journal of medicinal chemistry (10.04.2008)
Get full text
Journal Article
Development of a Microplate-Based, Electrophoretic Fluorescent Protein Kinase A Assay: Comparison with Filter-Binding and Fluorescence Polarization Assay Formats
Miick, Siobhan M., Jalali, Shila, Dwyer, Brian P., Havens, John, Thomas, Donald, Jimenez, Manuel A., Simpson, Mathew T., Zile, Betsy, Huss, Karen L., Campbell, Robert M.
Published in Journal of biomolecular screening (01.06.2005)
Published in Journal of biomolecular screening (01.06.2005)
Get full text
Journal Article
Abstract 5245: Identification and characterization of the IDO1 inhibitor LY3381916
Dorsey, Frank C., Benhadji, Karim A., Sams, Lillian L., Young, Debra A., Schindler, John F., Huss, Karen L., Nikolayev, Alexander, Carpenito, Carmine, Clawson, David, Jones, Bonita, Faber, Andrew L., Thomas, James E., Haney, Steven A., Zhao, Gaiying, McMillen, William T., Smeal, Tod, Sall, Daniel J., Kalos, Michael D., Geeganage, Sandaruwan, Henry, James R.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts
Graff, Jeremy R, McNulty, Ann M, Hanna, Kimberly Ross, Konicek, Bruce W, Lynch, Rebecca L, Bailey, Spring N, Banks, Crystal, Capen, Andrew, Goode, Robin, Lewis, Jason E, Sams, Lillian, Huss, Karen L, Campbell, Robert M, Iversen, Philip W, Neubauer, Blake Lee, Brown, Thomas J, Musib, Luna, Geeganage, Sandaruwan, Thornton, Donald
Published in Cancer research (Chicago, Ill.) (15.08.2005)
Get full text
Published in Cancer research (Chicago, Ill.) (15.08.2005)
Journal Article
Patient equipment management: integrating a flexible alternative to purchase or lease
Huss, K L, Knowles, R L, Berghoff, L L, Regan, S
Published in Hospital materiel management quarterly (01.11.1991)
Get full text
Published in Hospital materiel management quarterly (01.11.1991)
Journal Article